Related Experiment Video
Updated: Apr 12, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM
Xue-Song Liu1, Matthew D Genet1, Jenna E Haines1
1Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Massachusetts.
Unlabelled:
The excessive metastatic propensity of melanoma makes it the most deadly form of skin cancer, yet the underlying mechanism of metastasis remains elusive. Here, mining of cancer genome datasets discovered a frequent loss of chromosome 19p13.3 and associated downregulation of the zinc finger transcription factor ZBTB7A in metastatic melanoma. Functional assessment of ZBTB7A-regulated genes identified MCAM, which encodes an adhesion protein key to melanoma metastasis. Using an integrated approach, it is demonstrated that ZBTB7A directly binds to the promoter and transcriptionally represses the expression of MCAM, establishing ZBTB7A as a bona fide transcriptional repressor of MCAM. Consistently, downregulation of ZBTB7A results in marked upregulation of MCAM and enhanced melanoma cell invasion and metastasis. An inverse correlation of ZBTB7A and MCAM expression in association with melanoma metastasis is further validated with data from analysis of human melanoma specimens.
Implications:
Together, these results uncover a previously unrecognized role of ZBTB7A in negative regulation of melanoma metastasis and have important clinical implications.
Insights
Researchers found that the zinc finger transcription factor ZBTB7A normally suppresses melanoma metastasis by repressing MCAM. Loss of ZBTB7A allows MCAM to increase, promoting cancer spread.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Melanoma is the deadliest skin cancer due to its high metastatic potential.
- The molecular mechanisms driving melanoma metastasis are not fully understood.
Purpose of the Study:
- To investigate the role of ZBTB7A in melanoma metastasis.
- To identify ZBTB7A-regulated genes involved in melanoma progression.
Main Methods:
- Analysis of cancer genome datasets to identify chromosomal alterations and gene expression changes in metastatic melanoma.
- Functional studies to assess the regulatory relationship between ZBTB7A and its target genes.
- Validation using human melanoma specimens.
Main Results:
- Frequent loss of chromosome 19p13.3 and ZBTB7A downregulation were observed in metastatic melanoma.
- ZBTB7A directly represses the expression of MCAM, a key adhesion molecule in melanoma metastasis.
- Downregulation of ZBTB7A leads to MCAM upregulation, increased melanoma cell invasion, and enhanced metastasis.
- An inverse correlation between ZBTB7A and MCAM expression was confirmed in human melanoma samples.
Conclusions:
- ZBTB7A acts as a tumor suppressor by inhibiting melanoma metastasis.
- ZBTB7A negatively regulates MCAM expression, thereby controlling melanoma cell invasion and spread.
- These findings reveal a novel mechanism in melanoma metastasis with potential clinical significance.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs

